Karachi: Ferozsons Laboratories Limited has announced that its Board of Directors will convene on September 29, 2026, at 11:45 a.m. via video link. The meeting is set to discuss the Annual Financial Results for the period ending June 30, 2026, and to decide on any potential entitlements.

The company has instituted a Closed Period from September 22 to September 29, 2026, in accordance with the Pakistan Stock Exchange Regulation 5.6.4. This move adheres to the standard protocols required for listed entities during crucial financial deliberations.

According to information available from the Pakistan Stock Exchange (PSX), such Closed Periods are routinely implemented to ensure compliance and maintain the integrity of financial proceedings.

Ferozsons Laboratories is categorized under the healthcare sector, with activities centered around the manufacturing and distribution of pharmaceutical products. The forthcoming board meeting will be pivotal in setting the financial tone for the company as it assesses its annual performance metrics and strategic financial planning.